文献速递其他结缔组织病

肌肉FDG摄取PET-CT作为炎性肌病疾病活动度生物标志物的评估

Muscle fluorodeoxyglucose uptake assessed by positron emission tomography-computed tomography as a biomarker of inflammatory myopathies disease activity.
PubMed 文献 · Rheumatology (Oxford) · 2019-03-08

该研究在34例炎性肌病患者(44次PET-CT)和20例匹配对照中,建立了一种简化的PET-CT肌肉疾病活动度评分(mSUVmax),并评估其信度、效度和反应性。结果显示mSUVmax在患者中升高,可区分高与低肌肉疾病活动度,检测活动度变化的曲线下面积为0.96(95%CI 0.84, 1),反应性强且评分者间信度优秀。

要点

  • mSUVmax取双侧8块近端肌肉共16个SUVmax均值,经肝脏平均SUV归一化。
  • 以肌炎意向治疗活动指数为金标准,mSUVmax可区分高与低肌肉疾病活动度。
  • 检测肌肉疾病活动度变化的AUC为0.96(95%CI 0.84, 1),反应性强。

核心结论

  • PET-CT作为癌症筛查工具有助于测量炎性肌病患者肌肉疾病活动度及其演变。

研究设计与样本

  • 回顾性分析34例炎性肌病患者的44次PET-CT检查(癌症筛查时进行)和20例匹配对照的20次PET-CT检查(肺结节良性结论)。
  • 在8块近端肌肉双侧记录SUVmax,mSUVmax定义为16个肌肉SUVmax值的平均值,经肝脏平均SUV归一化。

主要发现

  • 炎性肌病患者mSUVmax较对照升高。
  • 以肌炎意向治疗活动指数为金标准,mSUVmax可识别高与低肌肉疾病活动度患者。
  • 在后续有复查的患者中,该方法检测肌肉疾病活动度变化的AUC为0.96(95%CI 0.84, 1)。
  • 反应性强,评分者间信度优秀。

关键数值与推荐

  • mSUVmax为16块近端肌肉SUVmax平均值经肝脏平均SUV归一化。
  • 检测肌肉疾病活动度变化的AUC为0.96(95%CI 0.84, 1)。

临床怎么用

  • 对炎性肌病患者,可利用癌症筛查时进行的PET-CT同时评估肌肉疾病活动度及其变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To devise a simple PET-CT score for measurement of muscle disease activity in patients with inflammatory myopathies (IMs) and to assess its validity. METHODS: A total of 44 PET-CT examinations in 34 IM patients (performed during cancer screening) and 20 PET-CT examinations in matched controls (investigated for pulmonary nodules with a conclusion of benignity) were analysed. Maximal standardized uptake values (SUVmax) were recorded bilaterally in eight proximal muscles. The muscle SUVmax (mSUVmax) was defined as the average of the 16 muscle SUVmax values, normalized on the liver mean SUV. Reliability, validity and responsiveness were evaluated. RESULTS: The mSUVmax was increased in IM patients compared with controls. This index allowed the identification of patients with high vs low muscle disease activity using the myositis intention to treat activity index as the gold standard. In patients with subsequent examinations, our method showed good accuracy to detect changes in muscle disease activity [area under the curve 0.96 (95% CI 0.84, 1)]. Responsiveness was strong. Interrater reliability was excellent. CONCLUSION: PET-CT, a non-invasive tool useful for cancer screening, is also valuable to measure muscle disease activity and its evolution in IM patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Matuszak J, Blondet C, Hubelé F, et al. Muscle fluorodeoxyglucose uptake assessed by positron emission tomography-computed tomography as a biomarker of inflammatory myopathies disease activity. Rheumatology (Oxford). 2019. PMID: 30851092. doi:10.1093/rheumatology/kez040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。